ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
What is the Confidence of this Pharmaceutical Company To Target its Sales Peak of CNY 10 Billion? Xiaobin/PharmaSources
August 07, 2023Recently, at Everest Medicines' investor exchange activities, the management led by CEO Luo Yongqing put forward the target of "realizing the marketing of four commercial products in a short time, with a sales peak of CNY 10 billion". -
FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease FDA
December 16, 2021FDA has granted accelerated approval for?Tarpeyo (budesonide) delayed release capsules to reduce proteinuria (increased protein levels in the urine) in adults with primary immunoglobulin A (IgA) nephropathy at risk of rapid disease progression. -
Omeros Finalizes with FDA Clinical Plan for OMS721 Approval in IgA Nephropathy americanpharmaceuticalreview
January 21, 2019Omeros has finalized its clinical plan for OMS721 submission and approval in immunoglobulin A nephropathy (IgAN) following a recent meeting with the U.S. Food and Drug Administration (FDA).....
Pharma Sources Insight January 2025
